PharmaCyte Biotech, Inc. (PMCB) stock
Close on Nov 12, 2026Market cap $4.32MP/E –Yield –
PharmaCyte Biotech statistics
67 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- –
- Last ex-dividend date
- No dividends
- Fundamentals through
- Jul 31, 2026
- Share price as of
- Nov 12, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 0.16
- 2.29
Share statisticsIndustry
- Shares Change (YoY)
- 14.3%
- 10.9%
- Shares Change (QoQ)
- 0.00%
- 0.48%
- Float
- 10M
- 49M
- Shares Held by Insiders
- 7.08%
- 12.1%
- Shares Held by Institutions
- 7.10%
- 56.4%
Short sellingIndustry
- Short Interest
- 50,675
- –
- Short Interest Change
- -27.7%
- -0.76%
- Short % of Float
- 0.51%
- 9.06%
- Short % of Shares Outstanding
- 0.47%
- 6.30%
- Days to Cover
- 1.19
- 5.13
Stock price statisticsIndustry
- 52-Week High
- $1.51
- –
- 52-Week Low
- $0.25
- –
- 20-Day Moving Average
- $0.36
- –
- 50-Day Moving Average
- $0.40
- –
- 200-Day Moving Average
- $0.62
- –
- Average True Range (14)
- $0.05
- –
- Price Change (1 Week)
- 7.14%
- 1.51%
- Price Change (1 Month)
- 15.4%
- -2.37%
- Price Change (3 Months)
- -27.0%
- -21.1%
- Price Change (6 Months)
- -57.7%
- -22.8%
- Price Change (YTD)
- -44.5%
- -22.6%
- Price Change (1 Year)
- -54.2%
- -21.0%
- Price Change (3 Years)
- -81.2%
- -24.8%
- Price Change (5 Years)
- -85.8%
- -76.9%
- Price Change (10 Years)
- -99.1%
- -63.2%
- Average Volume (10 Days)
- 335,459
- –
- Average Volume (20 Days)
- 185,365
- –
- Average Volume (90 Days)
- 193,165
- –
- Relative Volume
- 2.17
- 0.80
- Relative Strength Index (14)
- 57.1
- 44.7
- Volatility (1 Year)
- 101.1%
- 80.2%
- Beta (5 Years)
- 0.76
- 1.07
Returns on capitalIndustry
- Return on Equity (ROE)
- -70.6%
- -51.3%
- Return on Assets (ROA)
- -52.9%
- -40.7%
- Return on Invested Capital (ROIC)
- -56.0%
- -32.9%
- Return on Capital Employed (ROCE)
- -19.1%
- -38.1%
Financial positionIndustry
- Current Ratio
- 40.30
- 3.31
- Quick Ratio
- 23.21
- 2.41
GrowthIndustry
- Net Income Growth (YoY)
- -163.4%
- -14.4%
EfficiencyIndustry
- Asset Turnover
- 0.00
- 0.40
- Revenue Per Employee
- $0
- $429.38K
- Profits Per Employee
- -$9.71M
- -$683.67K
- Employee Count
- 2
- 75
- WACC
- 8.69%
- 10.0%
Income statement (TTM)Industry
Balance sheetIndustry
- Net Cash (Debt)
- $17.84M
- $16.98M
- Net Cash Per Share
- $1.66
- $0.72
- Equity (Book Value)
- $27.51M
- $52.68M
- Book Value Per Share
- $2.56
- $1.50
- Tangible Book Value
- $27.51M
- $26.74M
- Working Capital
- $30.21M
- $78.52M
Cash flow (TTM)Industry
Dividends and yieldsIndustry
- Earnings Yield
- -450.1%
- -21.0%
- Buyback Yield
- 9.31%
- -0.73%
- Shareholder Yield
- 9.31%
- 0.00%
Scores and fair valueIndustry
- Altman Z-Score
- -3.43
- 0.26
- Piotroski F-Score
- 3
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | PMCB | S&P 500 | Difference | PMCB per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +10.1% | -2.7% | +12.8 pts | ||
| 3 months | -26.6% | -1.7% | −24.8 pts | ||
| Year to date | -44.5% | +11.9% | −56.4 pts | ||
| 1 year | -52.8% | +12.0% | −64.8 pts | ||
| 3 years | -81.5% | +78.2% | −159.7 pts | -43.0% | +21.2% |
| 5 years | -85.8% | +73.2% | −159.0 pts | -32.3% | +11.6% |
| 10 years | -99.1% | +309.6% | −408.7 pts | -37.5% | +15.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
0M PMCB shares were sold short on Oct 30, 2026, down 27.7% from the previous report, or 0.51% of the shares available to trade. At recent volumes it would take 1.2 days to buy them back. Over the last 20 sessions, 25.0% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 50,675 | -27.7% | 42,490 | 1.2 |
| Oct 15, 2026 | 70,104 | -47.6% | 99,423 | 1.0 |
| Sep 30, 2026 | 133,885 | +90.1% | 533,557 | 1.0 |
| Sep 15, 2026 | 70,436 | -11.7% | 238,194 | 1.0 |
| Aug 31, 2026 | 79,793 | -61.7% | 91,412 | 1.0 |
| Aug 14, 2026 | 208,161 | -28.7% | 99,878 | 2.1 |
| Jul 31, 2026 | 291,960 | -9.4% | 152,996 | 1.9 |
| Jul 15, 2026 | 322,410 | -1.1% | 75,759 | 4.3 |
| Jun 30, 2026 | 326,126 | -7.0% | 103,473 | 3.1 |
| Jun 15, 2026 | 350,616 | -6.8% | 125,362 | 2.8 |
| May 29, 2026 | 376,378 | -19.9% | 243,939 | 1.5 |
| May 15, 2026 | 469,898 | +356.3% | 382,797 | 1.2 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?